Sign up to save your podcasts
Or
Share Kneat.com: A Conversation with Co-Founder & CEO Eddie Ryan
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Kneat.com: A Conversation with Co-Founder & CEO Eddie Ryan
In this conversation, Eddie Ryan, Co-Founder and CEO of Kneat.com, shares his journey from a mechanical engineer to leading a company that provides digital validation solutions for the health & life sciences industry. Eddie Ryan discusses the competitive landscape, the impact of their first major customer Biogen, and Kneat.com's growth strategy. Eddie highlights the importance of regulatory compliance, the integration of AI, and the company's strong focus on customer value. He also reflects on the challenges of scaling Kneat.com and offers insights for aspiring entrepreneurs.KEY TAKEAWAYS:
- Kneat.com was founded to address inefficiencies in validation processes
- Kneat.com operates on a land and expand model for growth
- The total addressable market for validation services is significant
- AI integration into the Kneat platform is a key focus for future development
- Kneat.com has grown from 35 employees to over 300
- Regulatory compliance is crucial in the life sciences industry
Ownership Disclosure: Kneat.com ($KSI) - No
#investing #stocks #personalfinance #wealth #podcast
🎙️WANT TO BE A GUEST? Email me at [email protected]
📰 SIGN UP TO MY FREE NEWSLETTER (JOIN 5,000+): https://robinspeziale.substack.com
📚 BUY MY BOOKS:
Market Masters: https://amzn.to/3Vfexu6
Capital Compounders: https://amzn.to/4eYP7bn
Lessons From The Successful Investor: https://amzn.to/3Zj2ai1
𝕏 FOLLOW ME: https://x.com/RobinSpeziale
💰 DOWNLOAD KOHO AND ADD $50 CASH TO GET $20 FREE: https://web.koho.ca/referral/UGXXKO6S
***
DISCLAIMER:
This content is for informational purposes only, and should not be construed as offering of investment advice or stock recommendations. This content is based on the author's independent analysis and research and does not guarantee the information's accuracy or completeness. The information contained in this video is subject to change without notice, and the author assumes no responsibility to update the information contained in this video. All information contained herein this video should be independently verified with the sources and companies mentioned. The author is not responsible for errors or omissions. The author does not purport to tell or suggest which investment securities viewers should buy or sell for themselves. Those viewers seeking direct investment advice should consult a qualified, registered, investment professional. The author is not a professional or financial advisor, and does not provide financial advice. Viewers are advised to conduct their own due diligence prior to considering buying or selling any stock. The author will not be liable for any loss or damage caused by a viewer's reliance on information obtained in any of this content. It’s important to understand that investing involves risk, including loss of principal. The author is not engaged in any investor relations agreements with any of the publicly traded companies mentioned. The author does not receive compensation of any kind from any publicly traded companies that are mentioned in any of this content. The author has acquired and may trade shares of some of the companies mentioned through open market transactions and for investment purposes only. Refer to the “author’s ownership disclosure” where applicable. There may be affiliate links to Amazon, and other companies in which the author is compensated if any of the affiliate products are purchased from Amazon.ca/.com or any other companies.
View all episodes
By Robin SpezialeIn this conversation, Eddie Ryan, Co-Founder and CEO of Kneat.com, shares his journey from a mechanical engineer to leading a company that provides digital validation solutions for the health & life sciences industry. Eddie Ryan discusses the competitive landscape, the impact of their first major customer Biogen, and Kneat.com's growth strategy. Eddie highlights the importance of regulatory compliance, the integration of AI, and the company's strong focus on customer value. He also reflects on the challenges of scaling Kneat.com and offers insights for aspiring entrepreneurs.KEY TAKEAWAYS:
- Kneat.com was founded to address inefficiencies in validation processes
- Kneat.com operates on a land and expand model for growth
- The total addressable market for validation services is significant
- AI integration into the Kneat platform is a key focus for future development
- Kneat.com has grown from 35 employees to over 300
- Regulatory compliance is crucial in the life sciences industry
Ownership Disclosure: Kneat.com ($KSI) - No
#investing #stocks #personalfinance #wealth #podcast
🎙️WANT TO BE A GUEST? Email me at [email protected]
📰 SIGN UP TO MY FREE NEWSLETTER (JOIN 5,000+): https://robinspeziale.substack.com
📚 BUY MY BOOKS:
Market Masters: https://amzn.to/3Vfexu6
Capital Compounders: https://amzn.to/4eYP7bn
Lessons From The Successful Investor: https://amzn.to/3Zj2ai1
𝕏 FOLLOW ME: https://x.com/RobinSpeziale
💰 DOWNLOAD KOHO AND ADD $50 CASH TO GET $20 FREE: https://web.koho.ca/referral/UGXXKO6S
***
DISCLAIMER:
This content is for informational purposes only, and should not be construed as offering of investment advice or stock recommendations. This content is based on the author's independent analysis and research and does not guarantee the information's accuracy or completeness. The information contained in this video is subject to change without notice, and the author assumes no responsibility to update the information contained in this video. All information contained herein this video should be independently verified with the sources and companies mentioned. The author is not responsible for errors or omissions. The author does not purport to tell or suggest which investment securities viewers should buy or sell for themselves. Those viewers seeking direct investment advice should consult a qualified, registered, investment professional. The author is not a professional or financial advisor, and does not provide financial advice. Viewers are advised to conduct their own due diligence prior to considering buying or selling any stock. The author will not be liable for any loss or damage caused by a viewer's reliance on information obtained in any of this content. It’s important to understand that investing involves risk, including loss of principal. The author is not engaged in any investor relations agreements with any of the publicly traded companies mentioned. The author does not receive compensation of any kind from any publicly traded companies that are mentioned in any of this content. The author has acquired and may trade shares of some of the companies mentioned through open market transactions and for investment purposes only. Refer to the “author’s ownership disclosure” where applicable. There may be affiliate links to Amazon, and other companies in which the author is compensated if any of the affiliate products are purchased from Amazon.ca/.com or any other companies.